Analogue W
ID: ALA1159782
PubChem CID: 44273315
Max Phase: Preclinical
Molecular Formula: C19H39N5O9
Molecular Weight: 481.55
Molecule Type: Small molecule
Associated Items:
This compound is not in our inventory system
ID: ALA1159782
PubChem CID: 44273315
Max Phase: Preclinical
Molecular Formula: C19H39N5O9
Molecular Weight: 481.55
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: NCCC1C(CO)OC(OC2C(O)C(N)CC(N)C2OC2OC(CN)C(O)C(O)C2N)C1O
Standard InChI: InChI=1S/C19H39N5O9/c20-2-1-6-10(5-25)31-19(12(6)26)33-17-13(27)7(22)3-8(23)16(17)32-18-11(24)15(29)14(28)9(4-21)30-18/h6-19,25-29H,1-5,20-24H2
Standard InChI Key: ZWMWMFQYDLHNHO-UHFFFAOYSA-N
Molfile:
RDKit 2D 33 35 0 0 0 0 0 0 0 0999 V2000 5.2917 -2.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6417 -0.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0125 -0.3792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.8792 -1.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2917 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.0917 -0.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2792 -2.1792 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2375 0.1208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.0542 -1.3292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.2292 -3.0667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 6.2125 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6792 0.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3625 -0.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8917 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.5667 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.8417 -1.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.5625 -1.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1667 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4375 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0042 -1.2042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 7.6667 -1.9417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.9417 1.1958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.8417 -6.4542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.2667 -0.7042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 5.5542 -0.7292 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 6.2042 -2.5417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.0417 0.5333 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.3542 0.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.8875 -5.2292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.5667 -5.2292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1667 -2.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.3667 -2.5417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.8500 -5.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 9 1 0 3 2 1 0 4 1 1 0 5 7 1 0 6 3 1 0 7 1 1 0 8 2 1 0 9 4 1 0 10 5 1 0 11 1 1 0 12 13 1 0 13 8 1 0 14 5 1 0 15 14 1 0 16 11 1 0 17 4 1 0 18 10 1 0 19 16 1 0 20 3 1 0 21 16 1 0 22 28 1 0 23 33 1 0 24 6 1 0 25 17 1 0 26 11 1 0 27 12 1 0 28 13 1 0 29 14 1 0 30 15 1 0 31 18 1 0 32 31 1 0 33 30 1 0 19 17 1 0 18 15 1 0 12 6 1 0 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.55 | Molecular Weight (Monoisotopic): 481.2748 | AlogP: -6.05 | #Rotatable Bonds: 8 |
Polar Surface Area: 268.17 | Molecular Species: BASE | HBA: 14 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.64 | CX Basic pKa: 10.07 | CX LogP: -6.36 | CX LogD: -13.59 |
Aromatic Rings: ┄ | Heavy Atoms: 33 | QED Weighted: 0.15 | Np Likeness Score: 1.58 |
1. Cashman DJ, Rife JP, Kellogg GE.. (2001) Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues., 11 (2): [PMID:11206440] [10.1016/s0960-894x(00)00615-6] |
Source(1):